We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug News
    • Trending
    • Commercial Operations
    • GMPs, Inspections and Audits
    • Postmarket Safety
    • Quality
    • Regulatory Affairs
    • Research and Development
    • Submissions and Approvals
    • FDAnews Drug Daily Bulletin
    • Drug Industry Daily
  • Device News
    • Trending
    • Commercial Operations
    • Inspections and Audits
    • Postmarket Safety
    • Quality
    • Regulatory Affairs
    • Research and Development
    • Submissions and Approvals
    • FDAnews Device Daily Bulletin
    • FDAnews Device Daily Bulletin Premium
  • Books
    • FDAnews Books Library
    • Drug Books
    • Device Books
  • Training/Events
    • Webinar Training Pass
    • Events
  • Resources
    • Form 483s Database
    • FDA Approved Drugs
    • eCFR and Guidances
    • White Papers
  • CenterWatch
  • About Us
    • The Company
    • Contact Us
  • Advertising
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Train SMEs to Survive Inspection Interviews: Types of Questions

Train SMEs to Survive Inspection Interviews: Types of Questions

November 12, 2014

An important part of any inspection readiness SOP is training subject matter experts to handle investigator interviews. FDA investigators can draw conclusions from what your SMEs say, what they don’t say, even the way they do or don’t say it.

Investigators typically ask several different kinds of questions that present varying levels of risk. Prepare your SMEs to recognize and respond to the following types.

  • Close-ended questions are narrowly focused and require only very brief answers; often a simple “yes” or “no” will do. They are usually employed to verify statements and address uncomplicated issues, for example, “Do you have a training program?  Do you have a CAPA procedure?  Is this your signature?” SMEs should avoid providing a broader response when they are asked a closed question.
  • Open-ended questions are designed to encourage the SME to talk and provide as much information as he or she wishes. They are very broad, such as “What can you tell me about …?” or “What do you think about …?” Investigators often use open-ended questions to obtain more detail while reviewing complicated or sensitive areas.  Instruct SMEs to provide fact-based answers, not responses based on opinion.
  • Leading questions are phrased to suggest what kind of answer the investigator is seeking, such as “You don’t believe that process is effective, do you?” An investigator may ask this type of question to see how the SME is going to react. As with open-ended questions, SMEs should refrain from providing their opinions and respond with just the facts.
  • Nondirective or neutral questions, such as “How do you like your job?” may appear in the early stages or throughout an inspection. Investigators often use these types of questions to establish basic facts and identify potential issues. Train your SMEs to keep in mind that their responses are never off the record during an inspection and they should always answer in an official manner. 
  • Assumptive questions—possibly the trickiest kind—are designed to put the interviewee at ease and imply that the investigator already knows and accepts the answer, so the SME feels free to provide information he or she might otherwise not have shared. An example of an assumptive question might be, “So your CAPA system does not require an investigation for all non-conformances?” Instruct SMEs to listen very carefully to these types of questions to ensure that the investigator’s understanding is correct.
  • Restatement of questions—The investigator may ask the same question multiple times of the same SME or different SMEs.  This is done to confirm facts and to ensure he or she is receiving consistent answers. Make sure that other SMEs are kept aware of the content of previous discussions so that they do not make statements that contradict previous answers.

Knowing when to stop talking is one of the most important skills SMEs should learn. Just as important, once the investigator has finished asking the question, SMEs should ensure they have understood it. Train SMEs to repeat the question to verify that they have understood it. When in doubt, asking for clarification is important and necessary to ensure that SMEs provide accurate, correct answers to an investigator.

In next week’s issue, we’ll cover how to train SMEs by simulating inspection interviews.

Contact Information:
Dave Gallup
GMPTraining.com, Inc.
18585 Coastal Highway
Unit 10, #149
Rehoboth, DE 19971
215-870-5665
dagallup@gmptraining.com
www.gmptraining.com

Upcoming Events

  • 04Apr

    Optimizing Quality Control Operations with Unified Quality

  • 20Apr

    Medical Device Enforcement: Latest Developments from the FDA, DOJ and FTC

  • 25Apr

    Effective Root Cause Analysis and CAPA Investigations for Drugs, Devices and Clinical Trials

  • 26Apr

    FDA’s New Laws and Regulations: What Drug and Biologics Manufacturers Need to Know

  • 27Apr

    Califf’s FDA, 2023 and Beyond: Key Developments, Insights and Analysis

  • 17May

    2023 WCG Avoca Quality Consortium Summit

Featured Products

  • FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485

    FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485

  • Selecting and Implementing Electronic Document Management Systems in the EU

    Selecting and Implementing Electronic Document Management Systems in the EU

Featured Stories

  • FDA Deems Cardiosave Intra-Aortic Balloon Recall Class I

  • Xtandi Shows Promise in Prostate Cancer Trial

  • Implantable Sleeve that Holds Spinal Screws in Place Gets FDA Clearance

  • FDA Green Lights Clinical Trial of Low-Dose Psilocybin

The Revised ICH E8: A Guide to New Clinical Trial Requirements

Learn More
  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell or Share My Data
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Toll free 888.838.5578

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing